Cas no 675856-55-0 ([4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid)
[4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid Chemical and Physical Properties
Names and Identifiers
-
- [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
- AKOS000302861
- CCG-121439
- 675856-55-0
- SR-01000298781-1
- 2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)aceticacid
- 2-[4-(2,5-dimethylphenyl)-2-methyl-1,3-thiazol-5-yl]acetic acid
- [4-(2,5-dimethylphenyl)-2-methyl-1,3-thiazol-5-yl]acetic acid
- SR-01000298781
- 2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid
-
- MDL: MFCD06253058
- Inchi: 1S/C14H15NO2S/c1-8-4-5-9(2)11(6-8)14-12(7-13(16)17)18-10(3)15-14/h4-6H,7H2,1-3H3,(H,16,17)
- InChI Key: QBWJUZWIXSEGQY-UHFFFAOYSA-N
- SMILES: S1C(C)=NC(=C1CC(=O)O)C1C=C(C)C=CC=1C
Computed Properties
- Exact Mass: 261.08234989Da
- Monoisotopic Mass: 261.08234989Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 18
- Rotatable Bond Count: 3
- Complexity: 310
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.2
- Topological Polar Surface Area: 78.4?2
[4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM377255-1g |
2-[4-(2,5-dimethylphenyl)-2-methyl-1,3-thiazol-5-yl]acetic acid |
675856-55-0 | 95%+ | 1g |
$323 | 2022-12-31 | |
| A2B Chem LLC | AX88288-100mg |
2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid |
675856-55-0 | 100mg |
$313.00 | 2024-04-19 | ||
| A2B Chem LLC | AX88288-250mg |
2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid |
675856-55-0 | 250mg |
$350.00 | 2024-04-19 | ||
| A2B Chem LLC | AX88288-500mg |
2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid |
675856-55-0 | 500mg |
$400.00 | 2024-04-19 | ||
| A2B Chem LLC | AX88288-1g |
2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid |
675856-55-0 | 1g |
$463.00 | 2024-04-19 | ||
| A2B Chem LLC | AX88288-5g |
2-(4-(2,5-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid |
675856-55-0 | 5g |
$1025.00 | 2024-04-19 |
[4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid Related Literature
-
Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
Additional information on [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
Comprehensive Overview of [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid (CAS No. 675856-55-0)
[4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid, identified by its CAS No. 675856-55-0, is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This thiazole derivative is characterized by its unique molecular structure, which includes a 2,5-dimethylphenyl group and a methyl-thiazole core. The compound's acetic acid moiety further enhances its reactivity, making it a valuable intermediate in the synthesis of more complex molecules.
Researchers are particularly interested in [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid due to its potential applications in drug discovery. The thiazole ring is a common pharmacophore found in many bioactive molecules, and modifications to this structure can lead to compounds with enhanced therapeutic properties. Current trends in AI-driven drug design and computational chemistry have further amplified the demand for such building blocks, as they are often used in virtual screening and molecular docking studies.
The synthesis of CAS No. 675856-55-0 involves multi-step organic reactions, including condensation and cyclization processes. Its purity and stability are critical for ensuring reproducibility in research applications. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to verify its structural integrity. This compound is often referenced in patents and scientific literature related to anti-inflammatory agents and metabolic modulators, aligning with the growing focus on precision medicine.
In the context of green chemistry, there is increasing scrutiny on the environmental impact of chemical synthesis. [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid is no exception, and researchers are exploring sustainable methods for its production. Solvent-free reactions and catalytic processes are among the innovative approaches being investigated to reduce waste and energy consumption.
From a commercial perspective, the global market for fine chemicals and pharmaceutical intermediates is expanding rapidly. CAS No. 675856-55-0 is part of this trend, with suppliers emphasizing high-purity grades to meet the stringent requirements of GMP compliance and regulatory standards. Its role in the development of small-molecule therapeutics underscores its importance in modern drug development pipelines.
For those seeking detailed technical data, the compound's physicochemical properties, such as solubility, melting point, and spectral data, are essential for experimental design. Additionally, safety data sheets (SDS) provide crucial information for handling and storage, ensuring compliance with laboratory safety protocols. The compound's stability under various conditions is also a topic of interest, particularly for long-term storage and transport.
In summary, [4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid (CAS No. 675856-55-0) represents a versatile and valuable tool in medicinal chemistry. Its applications span from drug discovery to material science, reflecting the interdisciplinary nature of contemporary research. As the scientific community continues to explore its potential, this compound is likely to remain a focal point in the development of next-generation therapeutics.
675856-55-0 ([4-(2,5-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)